Tcg Crossover Management, LLC Silence Therapeutics PLC Transaction History
Tcg Crossover Management, LLC
- $950 Million
- Q1 2024
A detailed history of Tcg Crossover Management, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 3,295,350 shares of SLN stock, worth $65.7 Million. This represents 7.49% of its overall portfolio holdings.
Number of Shares
3,295,350
Previous 2,104,875
56.56%
Holding current value
$65.7 Million
Previous $36.6 Million
94.69%
% of portfolio
7.49%
Previous 5.06%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
63Shares Held
27.1MCall Options Held
0Put Options Held
0-
Artal Group S.A. Luxembourg, N42.78MShares$55.5 Million3.24% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.39MShares$47.7 Million1.25% of portfolio
-
Lombard Odier Asset Management (Europe) LTD London, X02.24MShares$44.6 Million4.48% of portfolio
-
Redmile Group, LLC San Francisco, CA2.03MShares$40.5 Million1.73% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.64MShares$32.8 Million1.17% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $716M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...